Mtbvac clinical trials
How each study uses mtbvac is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the mtbvac studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 3
Biofabri, S.L (3) · International AIDS Vaccine Initiative (2) · Bharat Biotech International Limited (1) · HIV Vaccine Trials Network (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test mtbvac.
- Nov 2027Evaluating the Safety and Immunogenicity of MTBVACPhase 2 · HIV Vaccine Trials Network
Studies
Open first, then newest update. How each study uses mtbvac is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Evaluating the Safety and Immunogenicity of MTBVACRecruitingPhase 2HIV Vaccine Trials NetworkNCT05947890Written as MTBVAC
- Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan AfricaRecruitingPhase 3Biofabri, S.LNCT04975178Written as MTBVAC
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.Active, not recruitingPhase 2International AIDS Vaccine InitiativeNCT06272812Written as MTBVAC
- Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)Active, not recruitingPhase 2Bharat Biotech International LimitedNCT06997367Written as MTBVAC
- Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African NeonatesCompletedPhase 2Biofabri, S.LNCT03536117Written as MTBVAC
- MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South AfricaCompletedPhase 1/2International AIDS Vaccine InitiativeNCT02933281Written as MTBVAC
- Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in AdultsCompletedPhase 1/2Biofabri, S.LNCT02729571Written as MTBVAC